Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.

Antiviral therapy - 1 Jan 2007

Tarr Philip E, Telenti Amalio

Abstract excerpt

Metabolic complications of antiretroviral therapy (ART) have emerged as a major concern for long-term, successful management of HIV infection. Variability in the response to ART between individuals has been increasingly linked to the genetic background of patients, as regards efficacy and susceptibility to adverse reactions (toxicogenetics). This review summarizes the biological and methodological background for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Lipid Metabolism

Share to Mitochondria

Share to Polymorphism, Single Nucleotide

Share to Toxicogenetics

Source

Identifiers

PMID: 18018758

Genes

ABCA1
APOA5
APOC3
APOE
CETP
LMNA
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications.PMID 18018758Read ↗

The toxicogenetics of antiretroviral therapy: the evil inside.Semantic proximity Read ↗

Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.Semantic proximity Read ↗

Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.Semantic proximity Read ↗

Impact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.Semantic proximity Read ↗

Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV-associated lipodystrophy.Semantic proximity Read ↗

Adipogenic gene variants in patients with HIV-associated lipodystrophy.Semantic proximity Read ↗

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.Semantic proximity Read ↗

Pharmacogenetics of anti-HIV drugs.Semantic proximity Read ↗

Identification of novel genetic variations in ABCB6 and GRN genes associated with HIV-associated lipodystrophy.Semantic proximity Read ↗

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.Semantic proximity Read ↗

Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.Semantic proximity Read ↗

Pharmacogenetics of antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.